American Healthcare REIT financials
$51.90−0.23%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 |
|---|---|---|
| Revenue | $2.26B | $2.07B |
| Gross profit | $466.6M | $416.8M |
| Gross margin | 20.6% | 20.1% |
| Operating income | $163.8M | $129.6M |
| Net income | $69.8M | -$37.8M |
| Net margin | 3.1% | −1.8% |
| Diluted EPS | $0.42 | $-0.29 |
| EBITDA | $394.1M | $358.4M |
| Operating cash flow | $294.4M | $176.1M |
| Free cash flow | $165.9M | $84.1M |
| Diluted shares | 166.8M | 130.6M |
Balance sheet
| Period end | Dec 31 | Dec 31 |
|---|---|---|
| Cash & equivalents | $114.8M | $76.7M |
| Short-term investments | $0.00 | $0.00 |
| Total debt | $1.55B | $1.71B |
| Total assets | $5.43B | $4.49B |
| Total liabilities | $2.07B | $2.18B |
| Shareholders' equity | $3.36B | $2.30B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology